Weight-loss drugs' impact on cancer risk revealed in new study
Weight-loss medications and bariatric surgery have both been found effective at helping people shed excess pounds — and now a new study explores their link to obesity-related cancer (ORC) risk.
Obesity is a known risk factor for certain types of cancers, and has also been shown to impact cancer survival.
Obesity-related cancers include multiple myeloma, meningioma, adenocarcinoma of esophagus; stomach, colorectal, liver or bile duct, gallbladder, pancreas, uterus, ovary, renal-cell kidney, thyroid, and postmenopausal breast cancer, according to the Centers for Disease Control and Prevention (CDC).
Semaglutide Found To Have Shocking Benefit For Liver Disease Patients In New Study
Researchers at Clalit Health Services in Tel Aviv, Israel, conducted an observational study of the medical records of 6,356 participants aged 24 and older who had obesity and diabetes, with no history of obesity-related cancer.
Between 2010 and 2018, half of the participants took GLP-1 receptor agonists (GLP-1 RAs) — injectable medications for obesity and type 2 diabetes — with at least six drug purchases within 12 months. The other half underwent bariatric metabolic surgery (BMS).
Read On The Fox News App
After adjusting for other factors, the researchers determined that ORC occurred in 5.62 cases per 1,000 person-years in those who had the surgery, and in 5.89 cases per 1,000 person-years among those who took GLP-1s.
Overall, the study determined that "the direct effect of GLP1-RAs compared to BMS on the risk for ORC beyond their effects on weight-loss is estimated as 41% relative risk reduction."
Here's Why Belly Fat Is More Common As We Age, And 3 Ways To Prevent It
The findings were published in the journal eClinicalMedicine.
"The results point at the existence of additional pathways beyond weight loss in which GLP-1RAs contribute to the decreased risk for obesity-related cancer," lead study author Yael Wolff Sagy, PhD, head of research at Clalit Health Services, told Fox News Digital.
Niketa Patel, professor of molecular medicine with the USF Health Morsani College of Medicine in Tampa, Florida, noted that obesity is associated with chronic inflammation.
"GLP1-RAs are shown to reduce inflammation and thus decrease the risk of developing ORC," she told Fox News Digital. (Patel was not involved in the study.)
"Bottom line: Obesity can cause certain cancers, and treatment of obesity with GLP1-RA reduces the risk of only obesity-related cancers."
Dr. Britta Reierson, MD, medical director of knownwell, a provider of metabolic health services, said there are several ways in which GLP-1 RAs could have cancer mitigation properties.
"First, the anti-inflammatory properties of these medications address a known risk factor for various cancers," the Minnesota-based doctor, who also was not part of the research, told Fox News Digital.
"Second, the metabolic regulation and improvement in metabolic health from these medications, including lowering blood glucose levels and decreasing insulin resistance, can reduce cancer risk."
Emerging evidence also suggests that GLP-1 RAs may have direct anti-tumor effects, Reierson noted — "potentially through modulation of immune responses and epigenetic changes (changes that occur to gene expression and are passed down to future generations)."
First Glp-1 Pill For Weight Loss, Diabetes Shows Success In Late-phase Trial
Research suggests that GLP-1 medications help reduce inflammation not just through weight loss, but also in other organs of the body, such as the heart, according to Dr. Susan Savery, MD, a board-certified obesity medicine and primary care physician with PlushCare, a virtual health platform offering primary care, therapy and weight management services.
"Over time, chronic inflammation can be a risk factor for cancer development, as it may damage cell DNA," San Francisco-based Savery, who was not involved in the study, told Fox News Digital.
"Our fat cells (adipose tissue) naturally produce inflammatory cells, and GLP-1 medications, similar to bariatric surgery, help reduce this inflammation by decreasing the amount of adipose tissue through weight loss."
The study did have some limitations, the researchers acknowledged.
"First, it is an observational study. It means that our comparison groups (persons who had surgery versus those who received GLP1-RAs) may still have some residual differences, despite our methodological efforts," Sagy told Fox News Digital.
"However, only this type of real-life observational study can provide the long follow-up period that is necessary to evaluate the risk of developing cancer, which often has very long latency periods."
Another limitation is that the primary drug included in the study was liraglutide (Saxenda, Victoza), with smaller numbers of people taking exenatide (Byetta) and dulaglutide (Trulicity).
"It will be important to evaluate the comparative effectiveness of the newer GLP1-RA drugs, which are expected to have a larger effect," Sagy said.
"Although the direction of the results is promising, we should wait and see if and how clinical guidelines will consider it."
Click Here To Sign Up For Our Health Newsletter
Reierson agreed that much more research is needed before GLP-1 RAs could ever be considered as cancer prevention options.
"Larger, randomized, controlled trials are necessary to confirm the observed effects and better understand the underlying mechanisms," she said.
"It will also be important to investigate the impact of GLP-1 RAs on different types of cancer and assess the long-term safety and potential side effects of using GLP-1 RAs as a cancer therapy."
Savery agrees that it's likely too early to predict FDA approval for cancer therapy, but noted that "weight reduction plays an important role in cancer prevention, and GLP-1s seem to offer an additional benefit through inflammation reduction."
For more Health articles, visit www.foxnews.com/health
While GLP-1 RAs are "wonderful tools" that can support people on weight-loss journeys, Savery pointed out that maintaining a healthy lifestyle through nutritious eating and regular physical activity is "the foundation for cancer prevention and better overall health."Original article source: Weight-loss drugs' impact on cancer risk revealed in new study
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
29 minutes ago
- Wall Street Journal
Omada Health IPO to Price at $19 a Share as GLP-1s Fuel Interest
Omada Health is making its public-market debut, propelled by Americans' renewed focus on how weight affects physical health. The virtual healthcare platform on Friday will start trading publicly after 14 years of providing support to patients with weight-related chronic illnesses. Leadership sees the current moment as the perfect time for an IPO, as GLP-1 drugs such as Ozempic, Wegovy and Mounjaro have sparked renewed focus on health problems that can stem from obesity, President Wei-Li Shao said.
Yahoo
an hour ago
- Yahoo
New Research: Childhood Vaccination Rates Drop Across 1,600 U.S. Counties
Childhood vaccination rates have markedly declined across the U.S. since the start of COVID, according to new Johns Hopkins University research showing 78% of more than 2,000 counties reported drops and the average immunization rate had fallen to 91% — further below the 95% threshold needed for herd immunity While existing Centers for Disease Control and Prevention data has historically shown broadly declining measles-mumps-rubella vaccination rates at the state and national levels, the county-level analysis published this week in JAMA is far more granular. Get stories like this delivered straight to your inbox. Sign up for The 74 Newsletter It provides a 'better understanding of these pockets where you have more exceptionally high risk,' said senior author Lauren Gardner, the director of Johns Hopkins University's Center for Systems Science and Engineering. 'Knowing where there are problem areas,' she added, 'gives policymakers and public health professionals locations to target their limited resources to try and improve vaccination coverage and therefore minimize the potential risk of measles outbreaks.' The country is currently experiencing a deadly measles outbreak that has infected over 1,000 people across 30 states and killed two unvaccinated children. Case numbers this year have already surpassed 2024's total and mark the second-highest number of confirmed cases in a year since the disease was declared eradicated in the U.S. in 2000. Some 96% of reported infections have involved a person who was unvaccinated or whose status was unknown and 13% have resulted in hospitalization. Related Gardner, who also led the data collection efforts behind Johns Hopkins' COVID-19 dashboard, and her team collected county-level, two-dose MMR vaccine rates for kindergarteners from each state's department of health website from 2017 to 2024, where available. Ultimately, they were able to analyze trends in 2,066 counties across 33 states and made all their data available to download. While state level average rates may decline by a few percentage points, the researchers found 130 counties where they dropped by at least 10 percentage points, and in 15 of those counties, they plummeted more than 20. Only four of the states studied — California, Connecticut, Maine and New York — reported an increase in the median county-level vaccination rate. They are currently the only four states that exclusively allow medical — and not philosophical or religious — exemptions to mandatory vaccines for school-aged children. Related Gardner said she pursued the county-level data after observing growing vaccine hesitancy and misinformation. Based on her years of work in the field, she said she was '100% expecting to see [these current outbreaks].' If vaccination rates continue to drop 'measles is likely to return to endemic levels in the US,' according to the Johns Hopkins' report — a concern other experts see as heightened by Robert F. Kennedy Jr. now heading the U.S. Department of Health & Human Services. A well-known vaccine skeptic, Kennedy initially downplayed the measles spread in late February and has been inconsistent in his support of the MMR vaccine. Related Under Kennedy's leadership, the Trump administration released the controversial 'Make America Healthy Again' report on May 22, which misinterpreted studies, cited ones that don't exist and is suspected of being generated in part by artificial intelligence. The report, which involved no pediatricians, questions the safety and importance of some childhood vaccines. 'Despite the growth of the childhood vaccine schedule,' the report reads, 'there has been limited scientific inquiry into the links between vaccines and chronic disease, the impacts of vaccine injury, and conflicts of interest in the development of the vaccine schedule.' Related Paul Offit, the director of the Vaccine Education Center at the Children's Hospital of Philadelphia and a professor of pediatrics at the University of Pennsylvania Perelman School of Medicine, pushed back on these assertions. The issue has been well studied, and there is no evidence of links between childhood vaccines and chronic diseases — including diabetes and autism — said Offit, who is also a voting member of the CDC's Advisory Committee on Immunization Practices. He referenced 24 studies across seven countries and three continents involving thousands of children that show they're at no greater risk of developing autism if they receive the MMR vaccine. Current skepticism is not isolated to the measles vaccine: The Food and Drug Administration, which falls under HHS, recently released updated guidance which no longer recommends the COVID vaccine for healthy children or pregnant women. In response, a top COVID vaccine adviser at the CDC resigned this week, according to reporting from The Washington Post. And across the country, numerous states have introduced legislation to loosen vaccine requirements for school-aged children, opening the door for more parents to opt their kids out. 'I think this is only going to get worse,' Offit said. 'I think vaccines are under attack. You have a secretary of Health and Human Services who will do everything he can during the years that he is in that position to make vaccines less available, less affordable and more feared. … So I think this is a dangerous time to be a child in the United States of America.'
Yahoo
an hour ago
- Yahoo
FOIA Friday: Connolly questioned public health agency FOIA accessibility before his death
(Photo by Getty Images) One of the less noticed features of the Virginia Way is the long-running tendency of the commonwealth's leaders to conduct their decision-making behind closed doors. While the Virginia Freedom of Information Act presumes all government business is by default public and requires officials to justify why exceptions should be made, too many Virginia leaders in practice take the opposite stance, acting as if records are by default private and the public must prove they should be handled otherwise. In this feature, we aim to highlight the frequency with which officials around Virginia are resisting public access to records on issues large and small — and note instances when the release of information under FOIA gave the public insight into how government bodies are operating. Shortly before his late-May death, U.S. Rep. Gerry Connolly, D-Fairfax, expressed concern about the termination of Centers for Disease Control and Prevention staffers who handled Freedom of Information Act requests. It was one of his final acts as a member of Congress before passing away following an extended battle with cancer. In his letter to the CDC's acting director, Connolly said that 'the elimination of staff responsible for facilitating FOIA strongly implies an effort by the administration to prevent the public from obtaining information about their government that they are entitled to request.' The staff cuts come as FOIA officers at the Food and Drug Administration, National Institutes of Health, and other agencies within the Department of Health and Human Services were also let go. Connolly also pointed out that several outbreaks of infectious disease have been reported across the country. 'Now more than ever, maintaining transparency about the operations of the broader HHS — and CDC in particular — is crucial to understanding the government's capacity to respond to such crises.' Some outbreaks are currently noted on CDC's website, but with no FOIA-dedicated staff to handle records requests, it may be harder for journalists and citizens to seek further information that could aid public health. Records obtained by the Richmond Times-Dispatch show that a former Richmond Fire Department employee spent over $800,000 at a company registered to his home between 2017 and 2024. Reginald Thomas, a former analyst for RFD, used his city credit card, purchase orders and invoices to spend money at RPM Supply Co., LLC. The entity is registered to a house in Henrico County that he and his wife own. Though Richmond city officials did not say how much, if any, of the total was spent on legitimate products or services, they did confirm that he is no longer an employee. His conduct has since become the subject of two investigations — one by Richmond's auditor and another by the city's inspector general. The investigation into Thomas is among the latest actions the city has taken to address a history of funding issues tied to card misuse by employees. This spring, Mayor Danny Avula announced restrictions on employees' use of purchasing cards for several months while leaders re-evaluate how employee spending is handled overall. Last year, the inspector general found that nearly $500,000 in RIchmond tax dollars were wasted or misused through use of employees' cards. The Mercury's efforts to track FOIA and other transparency cases in Virginia are indebted to the work of the Virginia Coalition for Open Government, a nonprofit alliance dedicated to expanding access to government records, meetings and other state and local proceedings. Recently, Virginia's Department of Corrections announced and celebrated low recidivism rates, but not mentioned in the agency's news release was a note from the department's research team suggesting the achievement was due to the effects of COVID-19 on Virginia's court system. Recividism — when former prisoners reoffend and end up back in prison — is a metric law enforcement agencies often use to measure the success of rehabilitation programs or other efforts to lower crime rates. Prison reform advocates and rehabilitation advocates also view these metrics as either calls to action or reasons to celebrate programs that may benefit incarcerated people, their families, and the communities to which they return. The latest announcement from the state focuses on recidivism among former prisoners released between July 2020 and June 2021 and only examines people who returned to prison within three years of release — not those who were rearrested during the same time period, Richmond Times-Dispatch reported. About 17% of released prisoners landed back in prison, while 44% were rearrested, according to the report. While rearrests were higher, those numbers aren't counted as recidivism. Because the state's definition ties recidivism to reincarceration, it is influenced by how quickly courts deliver verdicts — and Virginia's courts were under emergency orders that slowed proceedings until the summer of 2022. 'Re-incarceration rates are lower during follow-up years impacted by COVID-19 due to court closures and sentencing delays,' the research team wrote in its report. Kyle Gibson, a spokesperson for VADOC, acknowledged that recidivism rates were lower due to COVID-19, 'but VADOC cannot conclusively say that the pandemic was the sole cause of the lower rates.' Attorney General Jason Miyares, who is seeking reelection this year, has emphasized on social media that the low recidivism rate supports his tough-on-crime approach as the state's top lawyer. In a post to X, he said there are two approaches to lowering the rate: 'hold violent repeat offenders accountable or let them out early.' 'For four years, I've fought to put violent criminals behind bars while leftist politicians demanded leniency and reduced sentences,' he added. 'We see which approach works.' While the recidivism rates have declined over the past decade, according to a Richmond Times-Dispatch analysis, the time frame that VADOC recently celebrated occurred prior to Miyares taking office. Without city council approval, the city of Roanoke overspent by $5 million last year, WSLS reported. A recent audit of expenditures found that the city's general fund exceeded the final budget. 'We are stewards of taxpayer dollars,' said newer council member Nick Hagen, who joined the city's legislative body after the issues occurred. 'They're not ours — they're the people's.' He suspected staff turnover might be part of the problem with lack of budget oversight. This is because the former city manager had stepped down, a successor was appointed, and a new city council took office. The audit also revealed that much of the overspending came from the Children's Services Act — which funds services for at-risk youth — and the city's fire department, which faced rising overtime costs and implemented pay increases. Still, to ensure spending is justified and remains within budget, WSLS reported that the city claimed to be implementing reforms. There will be more frequent budget reviews going forward, new staff will be hired, and stricter internal protocols will be put in place. Have you experienced local or state officials denying or delaying your FOIA request? Tell us about it: info@ SUPPORT: YOU MAKE OUR WORK POSSIBLE
